Targeting the Uncommon: A Case Report of Osimertinib Response in Advanced NSCLC Patient with Dual EGFR (E701fs and L702fs) Frameshift Deletions. - Wong, Angel Kwan Qi; Khan, Saqib Raza; Hadi, Danial Khan; Breadner, Daniel; Vincent, Mark David (Current Oncology, 2026)